All In Biotech

Drug Trial Radar · NCT04656795

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

A Single Dose, Non-Randomized, Open-Label, Parallel Group Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety and Tolerability of MT-7117 in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Last checked: Nov 20, 2026Latest source record: May 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Dec 2, 2020

Primary completion

Dec 4, 2021

Study completion Dec 9, 2021

Sponsor

Lead sponsor
Tanabe Pharma America, Inc.Industry
Sponsor type
Industry
First posted
Dec 7, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is an open-label, non randomised, single-dose, study in male and female subjects with renal impairment (severe and if required mild \& moderate) compared to male and female subjects with normal renal function.

Conditions

  • Renal Impairment
  • Normal Renal Function

Interventions

  • MT-7117Drug

    MT-7117

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum observed plasma concentration (Cmax) of MT-7117Time frame: Day 1 to 4
  2. Area under the plasma concentration time curve from time zero to the last quantifiable concentration (AUC0-last) of MT-7117Time frame: Day 1 to 4
  3. Area under the plasma concentration time curve from time zero to infinity (AUC0-∞) of MT-7117Time frame: Day 1 to 4

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Clinical Research Services (CRS) Kiel GmbH

    Kiel, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.